Work

Resistenzentwicklung unter Therapie mit dem Proteaseinhibitor VX-950 bei Patienten mit einer HCV Genotyp 1 Infektion

Year: 2006

Type: article

Source: Zeitschrift für Gastroenterologie

DOI: 10.1055/s-2006-950753

Authors: C Sarrazin, T Kieffer, D Bartels, B Hanzelka, U Müh, MW Welker, D Wincheringer, C Lin, S Purdy, C Weegink, H Reesink, S Zeuzem, A Kwong

Institutions: Universitätsklinikum des Saarlandes, Vertex Pharmaceuticals (United States), Amsterdam UMC Location University of Amsterdam

Language: German

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2624529232

FWCI:

Cites:

Cited by:

Related to: 10